HIV-1 Integrase is a validated drug target for anti-HIV therapy. It is an essential enzyme required for replication of the AIDS-virus. 1,3,4-oxadiazole substituted naphthyridine derivatives act against HIV integrase and thus have the potential to become a part of anti-HIV drug regime. In present study, we have carried out QSAR study of 1,3,4-oxadiazole substituted naphthyridine derivatives. Stepwise multiple linear regression analysis was performed to derive QSAR models and was evaluated for statistical significance and predictive power. The best QSAR model was selected for anti-HIV activity, having correlation coefficient (R) = 0.862, standard error of estimation (SEE) = 0.271 and cross validated squared correlation coefficient (Q2) = 0.676. The QSAR model indicates that shape index, partition coefficient and solvent accessible surface area play an important role in the anti-HIV activities of 1,3,4-oxadiazole substituted naphthyridine derivatives. The results of the present study may be useful in designing more potent analogues.
Read full abstract